MIMI I-NAN HU to Risk Factors
This is a "connection" page, showing publications MIMI I-NAN HU has written about Risk Factors.
Connection Strength
0.114
-
Cancer therapies and bone health. Curr Rheumatol Rep. 2010 Jun; 12(3):177-85.
Score: 0.028
-
Bone loss in patients with breast or prostate cancer. Curr Osteoporos Rep. 2007 Dec; 5(4):170-8.
Score: 0.023
-
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer. Oral Dis. 2022 Jan; 28(1):193-201.
Score: 0.014
-
Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience. J Bone Miner Res. 2016 08; 31(8):1569-76.
Score: 0.010
-
Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer. Thyroid. 2014 May; 24(5):918-22.
Score: 0.009
-
Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. Arch Surg. 2012 Apr; 147(4):338-44.
Score: 0.008
-
Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid. 2011 Feb; 21(2):189-92.
Score: 0.007
-
Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Ann N Y Acad Sci. 2011 Feb; 1218:47-54.
Score: 0.007
-
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res. 2008 Jun; 23(6):826-36.
Score: 0.006